Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner
10.1186/1475-2840-12-154
Saved in:
Main Authors: | Hausenloy D.J., Whittington H.J., Wynne A.M., Begum S.S., Theodorou L., Riksen N., Mocanu M.M., Yellon D.M. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
BioMed Central
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/143923 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction
by: Nattayaporn Apaijai, et al.
Published: (2018) -
Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction
by: Apaijai N., et al.
Published: (2017) -
Reducing myocardial infarct size: Challenges and future opportunities
by: Bulluck, H, et al.
Published: (2020) -
Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction
by: Inthachai T., et al.
Published: (2015) -
Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction
by: Tharnwimol Inthachai, et al.
Published: (2018)